Navigation Links
Despite Being Effective Electroconvulsive Therapy is Underused for Severe Depression

Electroconvulsive therapy (ECT) helps patients with severe depression who don't respond to other treatments, and should be considered more often in the earlier stages of the illness, according to an article of the Southern Medical Journal.

"Electroconvulsive therapy has been shown to be a highly effective, safe, and even life-saving treatment for persistent and severe depression, bipolar disorder, and schizophrenia," writes Dr. Stephen Taylor of the University of Louisville. Dr. Taylor reviews the history and current use of ECT for depression and other psychiatric disorders, making the case for increased use of this research-proven therapy.

The idea of inducing seizures to treat psychiatric disorders has a long history, but it wasn't until the 1950sa time when there were few effective treatments for serious mental illnessthat scientific studies confirmed the effectiveness of ECT. "The 'antipsychiatry movement' and the promise that drugs would cure mental illness contributed to a decline in ECT use in the ensuing decades," Dr. Taylor writes. Negative media depictions, as in the movie One Flew Over the Cuckoo's Nest, played a role as well.

However, "ECT has shown a strong comeback in the last decade, which is a testament to its continued efficacy and safety," according to Dr. Taylor. For patients with depression that does not improve with other drugs or treatments, ECT produces a response rate of up to 55 percent. Recent studies have reported even higher response rates80 to 90 percentwhen ECT is used as initial treatment for severe depression.

The procedure is very safe, with risks comparable to those of childbirth or minor surgery. Although concerns have been raised regarding memory loss as a side effect of ECT, this usually clears up within a few weeks. The procedure can be safely done in patients with various medical conditions, including pregnancy. Despite its effectiveness, there are still questions about h ow ECT works. Effects on brain neurotransmitters, such as serotonin, dopamine, and norepinephrine may be involved.

Several treatments are often needed to achieve a response to ECTalthough improvement may occur after the first session, patients typically receive six to twelve treatments. Dr. Taylor emphasizes, "For all patientsit should be stressed that ECT represents a treatment that will bring remission, not a cure." Many patients will need "maintenance" treatments over time, because the effects of ECT are temporary. Treatment can be repeated if the patient's depression relapses.

The article also updates key technical issues related to the performance of ECT, including different approaches to "dosing," electrode placement, medications, anesthesia, and patient evaluation and follow-up. "Although current wisdom has relegated ECT to a last treatment option in many cases, experience and emerging research have made it clear that ECT should be offered to patients as a viable option at all stages of their illness process," Dr. Taylor concludes.

An accompanying editorial by Dr. James N. Kimball of Wake Forest University Baptist Medical Center, Winston-Salem, N.C., echoes the call for physicians and patients to be open to the possibility of pursuing ECT for persistent depression and other disorders. "It is not right for everyone, but it is a treatment health professionals should consider in their therapeutic arsenal," Dr. Kimball writes. "[ECT] is one of the oldest treatments currently in modern psychiatry, but also one whose time has come."


'"/>




Related medicine news :

1. Most Smokers Continue To Smoke Despite Developing Cancer
2. Turkey Is Listed In The Christmas Meal Despite Bird Flu Scare
3. Being Active In Winter Despite That Inner Urge
4. Bail Granted To The Doctor Despite Her Patients Death
5. Despite More Studies Researchers Are Still Confound With ADHD
6. Nursing Home Residents Receive Appropriate Emergency Care Despite Poor Funds
7. Despite Collapse Of The Medicos Strike To Continue Unabated
8. Quality Of NHS Hospitals Getting Dirtier Despite Promises
9. Despite Ban, Asbestos Produce Goes Unhindered
10. US Senate Approves Embryo-research Plan Despite Presidents Refusal
11. Students Light Up Despite School Anti-Smoking Programs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2016)... Va. (PRWEB) , ... May 02, 2016 , ... “Engineering ... top honors at the 2016 ARRS Art Forum held recently at the Annual Meeting ... original creative expression among ARRS members and Annual Meeting attendees. , ...
(Date:5/2/2016)... Washington, DC (PRWEB) , ... May 02, 2016 ... ... the Results and Data Book for the 2016 Main Residency Match® (“the Match”), ... residency positions in United States teaching institutions. A record-high 30,750 positions were placed ...
(Date:5/2/2016)... Agoura Hills, CA (PRWEB) , ... May 02, 2016 , ... ... technology to provide his patients with same day treatments. In the past, many necessary ... from school or work, along with multiple anesthetic shots and extra chair time. Not ...
(Date:5/2/2016)... ... 2016 , ... East Los Angeles dentist , Dr. Ramin Assili, is ... to receive any dental extraction treatment for $40 off the regular price. This promotion ... the lower price, patients can more easily afford extractions to eliminate teeth that are ...
(Date:5/2/2016)... ... May 02, 2016 , ... This week Omega Institute, ... 2016 guest season which runs through October. Omega is offering a record 370 in-person ... , “There has never been such widespread interest in or need for the knowledge ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016   Acsis , a ... that leading IT market research and advisory firm IDC ... the IDC MarketScape: Worldwide Pharmaceutical Track and Trace Software ... report provides an assessment of the capabilities and business ... trace software market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... 27, 2016  Hologic, Inc. (Nasdaq: ... for the fiscal second quarter ended March 26, ... $0.24 increased 41.2%, and non-GAAP diluted EPS of ... 5.8% on a reported basis, and 6.3% on ... posted another good quarter, highlighted by 14.6% growth ...
(Date:4/27/2016)... TURIN, Italy , April 27, 2016 ... MR-guided linear accelerator (MR-linac) platform will be the focal ... annual meeting of the European Society for Radiotherapy & ... Elekta,s MR-linac integrates a state-of-the-art radiotherapy system and ... a physician to clearly see the patient,s anatomy in ...
Breaking Medicine Technology: